NEW THERAPEUTIC USES OF SMR1 PEPTIDES

Details for Australian Patent Application No. 2002236100 (hide)

Owner CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE INSTITUT PASTEUR

Inventors ROUGEON, Francois; ROUGEOT, Catherine

Pub. Number AU-A-2002236100

PCT Pub. Number WO2002/051435

Priority 00403670.3 22.12.00 EP

Filing date 24 December 2001

Wipo publication date 8 July 2002

International Classifications

G01N 033/50 Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine

A61P 027/00 Drugs for disorders of the senses

A61P 029/00 Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 025/00 Drugs for disorders of the nervous system

A61K 038/22 Medicinal preparations containing peptides - Hormones

Event Publications

23 January 2003 Application Open to Public Inspection

  Published as AU-A-2002236100

5 February 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002236101-Microbiocidal NphenylN-[4-(4-pyridyl-2-pyrimidin-2-YL]-amine derivatives

2002236099-SYSTEM, METHOD AND APPARATUS FOR WIRELESS CHANNEL PARAMETER ESTIMATION IN SPREAD SPECTRUM COMMUNICATION SYSTEMS